Figure 4: POCT for Antithrombotic Therapy

Many patients have indications for both anticoagulation (e.g., atrial fibrillation, venous thromboembolism, mechanical heart valve) and antiplatelet therapy (e.g., myocardial infarction or percutaneous coronary intervention). There is limited clinical trial data to guide the use of these agents in combination therapy. New diagnostics could aid selection and titration of combination regimens to personalize care by optimizing the risks of bleeding and clotting.

Categories

License

Elsevier user license